Edition:
International

Health News Headlines

U.S. doctors reconsider Pfizer's Paxlovid for lower-risk COVID patients

Use of Pfizer Inc's COVID-19 antiviral Paxlovid spiked this week, but some doctors are reconsidering the pills for lower-risk patients after a U.S. public health agency warned that symptoms can recur after people complete a course of the drug, and that they should then isolate a second time.

Factbox-Latest on the worldwide spread of the coronavirus

Shanghai took more gradual steps on Friday towards lifting its COVID-19 lockdown, while Beijing was investigating cases where its strict curbs were affecting other medical treatments as China soldiered on with its uneven exit from restrictions.

Politics Video

Politics News